Clinical trial
Q-SAM (Using QPOP to Predict Treatment for Sarcomas and Melanomas)
NCT04986748 is registered in ClinicalTrials.gov with National Cancer Centre, Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Q-SAM (Using QPOP to Predict Treatment for Sarcomas and Melanomas)
- Lead sponsor
- National Cancer Centre, Singapore
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 8, 2020
- Completion date
- December 31, 2028
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.